Implant Sciences Corporation (NYSE: IMX) reports a Q1 loss of $0.05 (from continuing operations) compared to a loss of $0.13 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE